8-K: Edgemode Secures $125K Working Capital via Dilutive Convertible Note

Edgemode, Inc. has entered into a securities purchase agreement to raise $125,000 in net proceeds through a convertible promissory note and the issuance of 1.25 million common shares.

Summary

• Edgemode, Inc. (the Company) entered into a securities purchase agreement with an accredited investor on November 26, 2025, effective November 18, 2025.
• The Company sold a convertible promissory note with a principal amount of $143,750, receiving net proceeds of $125,000, indicating an original issue discount of $18,750.
• The promissory note carries a one-time interest charge of 12%, applied to the principal on the issuance date, and matures on November 20, 2026.
• As additional consideration, the Company issued 1,250,000 shares of its common stock (Commitment Shares) to the investor.
• Proceeds from the sale of the promissory note are designated for working capital.
• The note is convertible into common stock after 180 days from issuance (or upon an event of default) at an initial conversion price of $0.01 per share.
• The conversion price can reset to $0.0075 if the common stock trades below $0.01 for more than 5 consecutive trading days, and further to the lowest traded price if it falls below $0.0075 for more than 5 consecutive trading days, with readjustments every 21 days while in default.
• The investor's beneficial ownership is capped at 9.99% of the Company's outstanding common stock upon conversion.
• The securities were issued in a private placement under Section 4(a)(2) of the Securities Act of 1933.

Sentiment

Score: 2

Explanation: The sentiment is very negative due to the highly dilutive nature of the financing, the extremely low conversion price with aggressive reset mechanisms, and the significant cost of capital for a relatively small amount of working capital. This type of financing is typically a last resort for companies facing severe financial constraints, indicating significant risk for existing shareholders.

Positives

• Secured $125,000 in net proceeds to be used for working capital, addressing immediate liquidity needs.
• The promissory note can be prepaid without penalty, offering flexibility to the Company.
• The Company covenants to maintain its corporate existence and listing on the OTC Markets or equivalent exchanges.

Negatives

• The financing involves significant dilution for existing shareholders through the issuance of 1,250,000 Commitment Shares and the convertible nature of the note.
• The conversion price of $0.01 per share, with potential resets to $0.0075 and even lower, suggests a very low valuation for the Company's common stock and high potential for further dilution.
• The effective interest rate is high, with a $18,750 discount on a $143,750 principal amount for $125,000 received, plus a 12% one-time interest charge, making the cost of capital substantial.
• The Company acknowledges the potentially dilutive effect of the conversion shares and states its obligation to issue them is absolute and unconditional.

Risks

• Significant stock price volatility risk due to the low conversion price and reset mechanisms, which could lead to substantial dilution if the stock price declines.
• Risk of delisting from OTC Markets or failure to comply with SEC reporting requirements, which are listed as events of default that would accelerate the note's repayment.
• The Company is a 'former shell company,' which may imply higher inherent risks, potential for regulatory scrutiny, and specific limitations on Rule 144 exemptions for resale of shares.
• Numerous events of default in the promissory note, including failure to maintain a bid price, changes in OTC Markets designation (e.g., Caveat Emptor), and inability to obtain Rule 144 legal opinions, could trigger immediate repayment.
• Restrictions on the Company's ability to pay dividends, make distributions, incur senior borrowings (with some exceptions), or sell significant assets without the holder's consent.

Future Outlook

The Company intends to use the net proceeds of $125,000 from this financing for working capital, which is crucial for its ongoing operations. The terms of the convertible note, particularly the low conversion price and reset mechanisms, suggest a future outlook that includes significant potential for equity dilution, especially if the Company's stock price remains low or declines further. The Company is obligated to honor conversions regardless of dilutive effect.

Management Comments

• The Company acknowledges and understands the potentially dilutive effect to the Common Stock upon the issuance of the Conversion Shares upon conversion of the Note.
• The Company further acknowledges that its obligation to issue Conversion Shares upon conversion of the Note is absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders.

Industry Context

This financing, characterized by a significant original issue discount, a high one-time interest charge, and highly dilutive conversion terms with downward resets, is typical for micro-cap companies, especially those with 'former shell company' status, seeking capital when traditional financing avenues are limited. Such terms often reflect a company in a challenging financial position, where access to capital comes at a high cost and significant shareholder dilution. The use of proceeds for 'working capital' further underscores operational needs rather than growth initiatives.

Comparison to Industry Standards

• The conversion price of $0.01 per share, with potential resets to $0.0075 and lower, is significantly below typical market prices for established public companies, indicating a distressed valuation similar to highly speculative penny stocks.
• The issuance of 1,250,000 'Commitment Shares' in addition to the convertible note is a common feature in highly dilutive financing arrangements for companies with limited access to capital, often seen in the junior mining or early-stage biotech sectors where cash burn is high and revenue is minimal.
• The 'former shell company' status, explicitly mentioned, places the Company in a higher risk category, often associated with stricter Rule 144 requirements and increased scrutiny, similar to companies like 'XYZ Biotech' or 'ABC Mining' that have undergone reverse mergers or significant corporate restructuring.
• The numerous and stringent events of default, including failure to maintain bid price or OTC Markets designation, are more common in high-risk debt instruments for companies struggling with compliance or market viability, unlike the more lenient terms typically offered to financially stable entities like 'Large Cap Tech Co' or 'Established Pharma Inc.'

Corporate Governance

Legal Proceedings

• The Company states that, except as disclosed in its public filings, there is no action, suit, claim, proceeding, inquiry or investigation pending or threatened against it or its subsidiaries that could have a material adverse effect.

Stakeholder Impact

• Shareholders: Face significant dilution from the issuance of 1,250,000 commitment shares and the potential conversion of the promissory note at very low, and potentially resetting, prices. This could severely depress per-share value.
• Creditors (Note Holder): Benefits from a high-yield, convertible instrument with strong protections, including numerous events of default and anti-dilution provisions, providing a favorable risk-reward profile for the investor.
• Management: Gains access to working capital but operates under restrictive covenants and the pressure of potential further dilution and accelerated repayment if covenants are breached or stock performance is poor.

Next Steps

• The Company will utilize the $125,000 net proceeds for working capital.
• The Company must comply with various covenants, including maintaining its corporate existence and stock listing on the OTC Markets.
• The Company will need to manage potential conversions of the promissory note into common stock, starting 180 days after the issue date or upon an event of default.

Key Dates

Recommendation

The terms of this financing are highly detrimental to existing shareholders. The significant original issue discount, high one-time interest, and the issuance of 1.25 million commitment shares immediately dilute equity. Furthermore, the extremely low initial conversion price of $0.01, coupled with aggressive downward reset mechanisms, creates a substantial overhang and guarantees further severe dilution if the stock price declines. This type of financing is typically a last resort for companies in distress, signaling significant underlying financial weakness and a high probability of continued share price erosion. A seasoned investor would view this as a strong indicator to exit the position.

Keywords

Convertible Note, Private Placement, Working Capital, Dilution, SEC Filing, 8-K, Edgemode Inc, Promissory Note, Equity Financing, Corporate Finance